Revvity provides life-science and diagnostics tools, reagents, instruments, and software used in research, clinical testing, and drug discovery. The company was formed from the rebranding of PerkinElmer’s life sciences and diagnostics businesses and serves academic labs, biopharma, and clinical laboratories. Its offerings span assay technologies, automated sample handling, and analytical solutions that help customers detect, measure, and analyze biological samples.
| Quarter | Revenue | YoY % | Earnings | YoY % |
|---|---|---|---|---|
| Q2 2025 | 720.3 | — | 54 | — |
| Q3 2025 | 699 | — | 46.6 | — |
| Q4 2025 | 772.1 | — | 98.4 | — |
| Q1 2026 | 711.1 | — | 40.7 | — |
| Q2 2026 | 729.7 | 1.3% | 51.8 | -3.9% |
All markets — KeepWinning global stock screener
Other companies on NYSE: Woori Financial Group Inc. (WF), FedEx Freight Holding Company, Inc. (FDXF), Clean Harbors, Inc. (CLH), Ball Corporation (BALL), Jacobs Solutions Inc. (J), Fair Isaac Corporation (FICO)